Why is JSS a strategic partner for your COVID-19 study development?

The JSS COVID-19 Task Force


  • We have a designated team which keeps abreast of the latest developments pertaining to SARS-CoV-2

  • We have a deep understanding and are fully aware of the challenges involved in the current treatment processes and testing protocols according to the regulations of various states and provinces

  • Scientific Affairs Group
    • COVID-19 Standard of Care and Competing Studies
    • COVID-19 Synopsis and Protocol Templates

  • Feasibility and Recruitment
    • We are securing potential sites in strategic territories
    • We are remaining up-to-date with changing patient availability
    • We are aware of differentiations between hospitals (Canada vs US), CHSLDs, long-term care facilities and SMOs

Our Clients

JSS Medical Research provides comprehensive clinical trial management services, from study design to publication of results, in Phase I-IV clinical trials across a broad range of therapeutic areas to the global pharmaceutical, biotechnology, medical device and nutraceutical industries. Biotechnology companies rely on the company's knowledgeable project teams, and its customer-centric and flexible approach to successfully conduct their critical early phase trials, while pharmaceutical companies can leverage its niche post-marketing service offerings.